Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. EPS (Diluted) for the year ending August 31, 2024: USD 0.05

Cannara Biotech Inc. EPS (Diluted) is USD 0.05 for the year ending August 31, 2024, a -9.22% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Cannara Biotech Inc. EPS (Diluted) for the year ending August 31, 2023 was USD 0.06, a 188.62% change year over year.
  • Cannara Biotech Inc. EPS (Diluted) for the year ending August 31, 2022 was USD 0.02, a 162.28% change year over year.
  • Cannara Biotech Inc. EPS (Diluted) for the year ending August 31, 2021 was USD -0.03, a 78.00% change year over year.
  • Cannara Biotech Inc. EPS (Diluted) for the year ending August 31, 2020 was USD -0.15, a 2.69% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email